Joseph Szgalsky, MD
Family Medicine · Glassboro, NJNPI 1689653644
Payments from drug & device makers
Across 226 payments — averaging $15.95 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$675
- AbbVie$599
- Abbott$529
- AstraZeneca$206
- GSK$206
- Astellas Pharma US Inc$181
- plus $1K from 30 others
What the payments were for
- Food & beverage$3,604100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 44 | $675 |
| AbbVie(2 entities) | 41 | $599 |
| Abbott | 25 | $529 |
| AstraZeneca | 14 | $206 |
| GSK | 14 | $206 |
| Astellas Pharma US Inc | 11 | $181 |
| Pfizer | 9 | $141 |
| Lilly USA, LLC | 9 | $134 |
| Daiichi Sankyo Inc. | 6 | $92 |
| Teva Pharmaceuticals USA, Inc. | 6 | $88 |
| Boehringer Ingelheim | 6 | $83 |
| Bayer | 4 | $83 |
| Novartis | 5 | $77 |
| Medtronic | 3 | $53 |
| Merck | 4 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $47 |
| Amgen | 3 | $41 |
| Hologic Sales And Service, LLC | 1 | $22 |
| Corcept Therapeutics | 1 | $21 |
| Otsuka America Pharmaceutical, Inc. | 1 | $21 |
| Inspire Medical Systems, Inc. | 1 | $20 |
| Biogen | 1 | $19 |
| Amneal Pharmaceuticals LLC | 1 | $19 |
| Exact Sciences | 1 | $18 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| Sanofi-aventis U.S. LLC | 1 | $17 |
| Idorsia Pharmaceuticals US Inc | 1 | $17 |
| Irhythm Technologies, Inc. | 1 | $16 |
| Biohaven Pharmaceuticals, Inc. | 1 | $15 |
| Johnson & Johnson | 1 | $15 |
| Kyowa Kirin, Inc. | 1 | $15 |
| Sanofi Pasteur Inc. | 1 | $14 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
| Ferring Pharmaceuticals Inc. | 1 | $13 |
| Circassia Inc. | 1 | $12 |
| Almatica Pharma LLC | 1 | $12 |
How this compares
$3,604 in reported general payments places this provider in the 80th percentile of 2,084 family medicine providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 79 | $79,570 |
| JardianceEmpagliflozin | 59 | $73,142 |
| XareltoRivaroxaban | 48 | $56,203 |
| JanuviaSitagliptin Phosphate | 36 | $49,934 |
| MounjaroTirzepatide | 35 | $41,517 |
| FarxigaDapagliflozin Propanediol | 23 | $27,674 |
| VascepaIcosapent Ethyl | 28 | $24,995 |
| TrulicityDulaglutide | 23 | $21,925 |
| TradjentaLinagliptin | 23 | $21,806 |
| Breo ElliptaFluticasone/Vilanterol | 34 | $19,252 |
| MyrbetriqMirabegron | 23 | $16,278 |
| Icosapent Ethyl | 43 | $15,355 |
| LinzessLinaclotide | 23 | $13,832 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 19 | $9,078 |
| AmbienZolpidem Tartrate | 13 | $8,177 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta | $83 | $94,94882 claims |
| PfizerEliquis | $141 | $79,57079 claims |
| Lilly USA, LLCMounjaro, Trulicity | $134 | $63,44258 claims |
| Johnson & JohnsonXarelto | $15 | $56,20348 claims |
| MerckJanuvia | $52 | $49,93436 claims |
| AstraZenecaFarxiga | $206 | $27,67423 claims |
| GSKBreo Ellipta, Arnuity Ellipta | $206 | $23,91350 claims |
| Astellas Pharma US IncMyrbetriq | $181 | $16,27823 claims |
| AbbVieLinzess | $599 | $13,83223 claims |
| Sanofi-aventis U.S. LLCAmbien | $17 | $8,17713 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $19 | $3,217233 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,084 family medicine providers in New Jersey.
Other family medicine in Glassboro
- Bac NguyenGlassboro$17K
- Howard HassmanClementon$47.1M
- Matthew HongNorth Cape May$15.3M
- Rubaba HussainClark$3.8M
- Gaurang BrahmbhattHoboken$2.6M
- Michael DobrowClifton$2.1M
- Mikhail VarshavskiChatham$1.4M
- Amit BhalodiaCamden$707K
- Jennifer AmicoNew Brunswick$627K
- Janet ColeFar Hills$466K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.